<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32244295</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2395</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21072395</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor neurons (MN). Importantly, MN degeneration is intimately linked to oligodendrocyte dysfunction and impaired capacity of oligodendrocyte precursor cells (OPCs) to regenerate the myelin sheath enwrapping and protecting neuronal axons. Thus, improving OPC reparative abilities represents an innovative approach to counteract MN loss. A pivotal regulator of OPC maturation is the P2Y-like G protein-coupled receptor 17 (GPR17), whose role in ALS has never been investigated. In other models of neurodegeneration, an abnormal increase of GPR17 has been invariably associated to myelin defects and its pharmacological manipulation succeeded in restoring endogenous remyelination. Here, we analyzed GPR17 alterations in the SOD1<sup>G93A</sup> ALS mouse model and assessed in vitro whether this receptor could be targeted to correct oligodendrocyte alterations. Western-blot and immunohistochemical analyses showed that GPR17 protein levels are significantly increased in spinal cord of ALS mice at pre-symptomatic stage; this alteration is exacerbated at late symptomatic phases. Concomitantly, mature oligodendrocytes degenerate and are not successfully replaced. Moreover, OPCs isolated from spinal cord of SOD1<sup>G93A</sup> mice display defective differentiation compared to control cells, which is rescued by treatment with the GPR17 antagonist montelukast. These data open novel therapeutic perspectives for ALS management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonfanti</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1280-9109</Identifier><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonifacino</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacy and Center of Excellence for Biomedical Research (CEBR), University of Genoa, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffaele</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2734-5418</Identifier><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanese</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3384-0666</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy and Center of Excellence for Biomedical Research (CEBR), University of Genoa, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgante</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Giambattista</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3744-5786</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy and Center of Excellence for Biomedical Research (CEBR), University of Genoa, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbracchio</LastName><ForeName>Maria P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0158-842X</Identifier><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GPR17ALS</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant><Grant><GrantID>PSR2017</GrantID><Agency>Universit&#xe0; degli Studi di Milano</Agency><Country/></Grant><Grant><GrantID>Department of Excellence 2018-2022</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C534979">GPR17 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009186" MajorTopicYN="N">Myelin Sheath</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073637" MajorTopicYN="N">Oligodendrocyte Precursor Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009836" MajorTopicYN="N">Oligodendroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">G protein-coupled receptor 17 (GPR17)</Keyword><Keyword MajorTopicYN="N">SOD1G93A ALS mouse model</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">montelukast</Keyword><Keyword MajorTopicYN="N">oligodendrocytes</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32244295</ArticleId><ArticleId IdType="pmc">PMC7177925</ArticleId><ArticleId IdType="doi">10.3390/ijms21072395</ArticleId><ArticleId IdType="pii">ijms21072395</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eisen A. Amyotrophic lateral sclerosis-evolutionary and other perspectives. Muscle Nerve. 2009;40:297&#x2013;304. doi: 10.1002/mus.21404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21404</ArticleId><ArticleId IdType="pubmed">19609920</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y., Homma K., Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv. Biol. Regul. 2016;60:95&#x2013;104. doi: 10.1016/j.jbior.2015.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2015.10.006</ArticleId><ArticleId IdType="pubmed">26563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafa&#x142;owska J., Dziewulska D. White matter injury in amyotrophic lateral sclerosis (ALS) Folia Neuropathol. 1996;34:87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">8791897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollink J., Hiemstra M., Miller K.L., Huszar I.N., Jenkinson M., Raaphorst J., Wiesmann M., Ansorge O., Pallebage-Gamarallage M., van Cappellen van Walsum A.M. White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 2019;45:570&#x2013;585. doi: 10.1111/nan.12555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12555</ArticleId><ArticleId IdType="pmc">PMC6852107</ArticleId><ArticleId IdType="pubmed">31002412</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Patani R. Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis. Stem Cells. 2018;36:293&#x2013;303. doi: 10.1002/stem.2758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2758</ArticleId><ArticleId IdType="pubmed">29235200</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Boulting G.L., Bobrowicz S., Eggan K.C. Human Embryonic Stem Cell-Derived Motor Neurons Are Sensitive to the Toxic Effect of Glial Cells Carrying an ALS-Causing Mutation. Cell Stem Cell. 2008;3:637&#x2013;648. doi: 10.1016/j.stem.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave K.A. Myelination and support of axonal integrity by glia. Nature. 2010;468:244&#x2013;252. doi: 10.1038/nature09614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09614</ArticleId><ArticleId IdType="pubmed">21068833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.W., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Bento-Abreu A., Nonneman A., Haeck W., Staats K., Geelen V., Hersmus N., K&#xfc;sters B., Van Den Bosch L., Van Damme P., et al. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain. 2013;136:471&#x2013;482. doi: 10.1093/brain/aws339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws339</ArticleId><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6496&#x2013;E6505. doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Chung A.Y., Na J.E., Lee S.J., Jeong S.H., Kim E., Sun W., Rhyu I.J., Park H.C. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis. Glia. 2019;67:1910&#x2013;1921.</Citation><ArticleIdList><ArticleId IdType="pubmed">31290185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecca D., Trincavelli M.L., Gelosa P., Sironi L., Ciana P., Fumagalli M., Villa G., Verderio C., Grumelli C., Guerrini U., et al. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS ONE. 2008;3:e3579. doi: 10.1371/journal.pone.0003579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003579</ArticleId><ArticleId IdType="pmc">PMC2570486</ArticleId><ArticleId IdType="pubmed">18974869</ArticleId></ArticleIdList></Reference><Reference><Citation>Boda E., Vigan&#xf2; F., Rosa P., Fumagalli M., Labat-Gest V., Tempia F., Abbracchio M.P., Dimou L., Buffo A. The GPR17 receptor in NG2 expressing cells: Focus on in vivocell maturation and participation in acute trauma and chronic damage. Glia. 2011;59:1958&#x2013;1973. doi: 10.1002/glia.21237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21237</ArticleId><ArticleId IdType="pubmed">21956849</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Daniele S., Lecca D., Lee P.R., Parravicini C., Douglas Fields R., Rosa P., Antonucci F., Verderio C., Letizia Trincavelli M., et al. Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation. J. Biol. Chem. 2011;286:10593&#x2013;10604. doi: 10.1074/jbc.M110.162867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.162867</ArticleId><ArticleId IdType="pmc">PMC3060511</ArticleId><ArticleId IdType="pubmed">21209081</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratangeli A., Parmigiani E., Fumagalli M., Lecca D., Benfante R., Passafaro M., Buffo A., Abbracchio M.P., Rosa P. The regulated expression, intracellular trafficking, and membrane recycling of the P2Y-like receptor GPR17 in Oli-neu oligodendroglial cells. J. Biol. Chem. 2013;288:5241&#x2013;5256. doi: 10.1074/jbc.M112.404996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.404996</ArticleId><ArticleId IdType="pmc">PMC3576128</ArticleId><ArticleId IdType="pubmed">23288840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceruti S., Villa G., Genovese T., Mazzon E., Longhi R., Rosa P., Bramanti P., Cuzzocrea S., Abbracchio M.P. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury. Brain. 2009;132:2206&#x2013;2218. doi: 10.1093/brain/awp147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp147</ArticleId><ArticleId IdType="pubmed">19528093</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke H., Parravicini C., Lecca D., Zanier E.R., Heine C., Bremicker K., Fumagalli M., Rosa P., Longhi L., Stocchetti N., et al. Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury. Purinergic Signal. 2013;9:451&#x2013;462. doi: 10.1007/s11302-013-9366-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-013-9366-3</ArticleId><ArticleId IdType="pmc">PMC3757149</ArticleId><ArticleId IdType="pubmed">23801362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Zhao C.Z., Zhang X.Y., Huang X.Q., Shi W.Z., Fang S.H., Lu Y.B., Zhang W.P., Xia Q., Wei E.Q. The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats. Neuroscience. 2012;202:42&#x2013;57. doi: 10.1016/j.neuroscience.2011.11.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.11.066</ArticleId><ArticleId IdType="pubmed">22155652</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigan&#xf2; F., Schneider S., Cimino M., Bonfanti E., Gelosa P., Sironi L., Abbracchio M.P., Dimou L. GPR17 expressing NG2-Glia: Oligodendrocyte progenitors serving as a reserve pool after injury. Glia. 2016;64:287&#x2013;299. doi: 10.1002/glia.22929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22929</ArticleId><ArticleId IdType="pubmed">26464068</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfanti E., Gelosa P., Fumagalli M., Dimou L., Vigan&#xf2; F., Tremoli E., Cimino M., Sironi L., Abbracchio M.P. The role of oligodendrocyte precursor cells expressing the GPR17 receptor in brain remodeling after stroke. Cell Death Dis. 2017;8:e2871. doi: 10.1038/cddis.2017.256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.256</ArticleId><ArticleId IdType="pmc">PMC5520912</ArticleId><ArticleId IdType="pubmed">28594400</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppolino G.T., Marangon D., Negri C., Menichetti G., Fumagalli M., Gelosa P., Dimou L., Furlan R., Lecca D., Abbracchio M.P. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination. Glia. 2018;66:1118&#x2013;1130. doi: 10.1002/glia.23305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23305</ArticleId><ArticleId IdType="pmc">PMC5900886</ArticleId><ArticleId IdType="pubmed">29424466</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Bonfanti E., Daniele S., Zappelli E., Lecca D., Martini C., Trincavelli M.L., Abbracchio M.P. The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization. Glia. 2015;63:2327&#x2013;2339. doi: 10.1002/glia.22896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22896</ArticleId><ArticleId IdType="pubmed">26228571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wu H., Wang S., Koito H., Li J., Ye F., Hoang J., Escobar S.S., Gow A., Arnett H.A., et al. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat. Neurosci. 2009;12:1398&#x2013;1406. doi: 10.1038/nn.2410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2410</ArticleId><ArticleId IdType="pmc">PMC2783566</ArticleId><ArticleId IdType="pubmed">19838178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Lecca D., Coppolino G.T., Parravicini C., Abbracchio M.P. Advances in Experimental Medicine and Biology. Volume 1051. Springer; New York, NY, USA: 2017. Pharmacological properties and biological functions of the GPR17 receptor, a potential target for neuro-regenerative medicine; pp. 169&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">28828731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., Ferrario S., Parravicini C., Capra V., Gelosa P., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 2006;25:4615&#x2013;4627. doi: 10.1038/sj.emboj.7601341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601341</ArticleId><ArticleId IdType="pmc">PMC1589991</ArticleId><ArticleId IdType="pubmed">16990797</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelosa P., Bonfanti E., Castiglioni L., Delgado-Garcia J.M., Gruart A., Fontana L., Gotti M., Tremoli E., Lecca D., Fumagalli M., et al. Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug. Pharmacol. Res. 2019;142:223&#x2013;236. doi: 10.1016/j.phrs.2019.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.02.025</ArticleId><ArticleId IdType="pubmed">30818044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou Z., Sun Y., Lin L., You N., Liu X., Li H., Ma Y., Cao L., Han Y., Liu M., et al. Olig2-targeted G-protein-coupled receptor Gpr17 regulates oligodendrocyte survival in response to lysolecithin-induced demyelination. J. Neurosci. 2016;36:10560&#x2013;10573. doi: 10.1523/JNEUROSCI.0898-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0898-16.2016</ArticleId><ArticleId IdType="pmc">PMC6601930</ArticleId><ArticleId IdType="pubmed">27733608</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Lecca D., Abbracchio M.P. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17. Neuropharmacology. 2016;104:82&#x2013;93. doi: 10.1016/j.neuropharm.2015.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.10.005</ArticleId><ArticleId IdType="pubmed">26453964</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifanese R., Averna M., De Tullio R., Pedrazzi M., Beccaria F., Salamino F., Milanese M., Bonanno G., Pontremoli S., Melloni E. Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis. J. Biol. Chem. 2010;285:631&#x2013;643. doi: 10.1074/jbc.M109.031674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031674</ArticleId><ArticleId IdType="pmc">PMC2804211</ArticleId><ArticleId IdType="pubmed">19880516</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Zappettini S., Onofri F., Musazzi L., Tardito D., Bonifacino T., Messa M., Racagni G., Usai C., Benfenati F., et al. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2011;116:1028&#x2013;1042. doi: 10.1111/j.1471-4159.2010.07155.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07155.x</ArticleId><ArticleId IdType="pubmed">21175617</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifanese R., Averna M., De Tullio R., Pedrazzi M., Milanese M., Bonifacino T., Bonanno G., Salamino F., Pontremoli S., Melloni E. Role of calpain-1 in the early phase of experimental ALS. Arch. Biochem. Biophys. 2014;562:1&#x2013;8. doi: 10.1016/j.abb.2014.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2014.08.006</ArticleId><ArticleId IdType="pubmed">25151305</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford A.H., Tripathi R.B., Richardson W.D., Franklin R.J.M. Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline. Cell Rep. 2016;15:761&#x2013;773. doi: 10.1016/j.celrep.2016.03.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.03.069</ArticleId><ArticleId IdType="pmc">PMC4850420</ArticleId><ArticleId IdType="pubmed">27149850</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergles D.E., Richardson W.D. Oligodendrocyte development and plasticity. Cold Spring Harb. Perspect. Biol. 2016;8:a020453. doi: 10.1101/cshperspect.a020453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020453</ArticleId><ArticleId IdType="pmc">PMC4743079</ArticleId><ArticleId IdType="pubmed">26492571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D., Hafezparast M., Bohnert S., Dick J.R.T., Martin J., Schiavo G., Fisher E.M.C., Greensmith L. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 2005;169:561&#x2013;567. doi: 10.1083/jcb.200501085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200501085</ArticleId><ArticleId IdType="pmc">PMC2171702</ArticleId><ArticleId IdType="pubmed">15911875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugliese A.M., Trincavelli M.L., Lecca D., Coppi E., Fumagalli M., Ferrario S., Failli P., Daniele S., Martini C., Pedata F., et al. Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTP&#x3b3;S binding and electrophysiological studies in 1321N1 cells. Am. J. Physiol. Cell Physiol. 2009;297:C1028&#x2013;C1040. doi: 10.1152/ajpcell.00658.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00658.2008</ArticleId><ArticleId IdType="pubmed">19625605</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;se M., Ritter K., Thiemke K., Gillard M., Kostenis E., M&#xfc;ller C.E. Development of [3H]2-carboxy-4,6-dichloro-1 H -indole-3-propionic acid ([3H]PSB-12150): A useful tool for studying GPR17. ACS Med. Chem. Lett. 2014;5:326&#x2013;330. doi: 10.1021/ml400399f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ml400399f</ArticleId><ArticleId IdType="pmc">PMC4027623</ArticleId><ArticleId IdType="pubmed">24900835</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva A.I., Haddon J.E., Ahmed Syed Y., Trent S., Lin T.C.E., Patel Y., Carter J., Haan N., Honey R.C., Humby T., et al. Cyfip1 haploinsufficient rats show white matter changes, myelin thinning, abnormal oligodendrocytes and behavioural inflexibility. Nat. Commun. 2019;10:1&#x2013;13. doi: 10.1038/s41467-019-11119-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11119-7</ArticleId><ArticleId IdType="pmc">PMC6671959</ArticleId><ArticleId IdType="pubmed">31371763</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C., Apolloni S., Parisi C., Amadio S. Purinergic contribution to amyotrophic lateral sclerosis. Neuropharmacology. 2016;104:180&#x2013;193. doi: 10.1016/j.neuropharm.2015.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.10.026</ArticleId><ArticleId IdType="pubmed">26514402</ArticleId></ArticleIdList></Reference><Reference><Citation>Cie&#x15b;lak M., Roszek K., Wujak M. Purinergic implication in amyotrophic lateral sclerosis&#x2014;From pathological mechanisms to therapeutic perspectives. Purinergic Signal. 2019;15:1&#x2013;15. doi: 10.1007/s11302-018-9633-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-018-9633-4</ArticleId><ArticleId IdType="pmc">PMC6439052</ArticleId><ArticleId IdType="pubmed">30430356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecca D., Raffaele S., Abbracchio M.P., Fumagalli M. Regulation and signaling of the GPR17 receptor in oligodendroglial cells. Glia. 2020;2:1&#x2013;11. doi: 10.1002/glia.23807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23807</ArticleId><ArticleId IdType="pubmed">32086854</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes E.G., Kang S.H., Fukaya M., Bergles D.E. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat. Neurosci. 2013;16:668&#x2013;676. doi: 10.1038/nn.3390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3390</ArticleId><ArticleId IdType="pmc">PMC3807738</ArticleId><ArticleId IdType="pubmed">23624515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Cattaneo L., Gallia E., Puliti A., Melone M., Provenzano F., Bossi S., Musante I., Usai C., Conti F., et al. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neuropharmacology. 2017;123:433&#x2013;445. doi: 10.1016/j.neuropharm.2017.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.06.020</ArticleId><ArticleId IdType="pubmed">28645622</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., Oliv&#xe1;n S., Osta R., Navarro X. Evolution of gait abnormalities in SOD1 G93A transgenic mice. Brain Res. 2011;1406:65&#x2013;73. doi: 10.1016/j.brainres.2011.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.06.033</ArticleId><ArticleId IdType="pubmed">21733494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S., Mansfield C., Jimenez-Moreno R., Moore V.D.G., Yoshikawa M., Hampton T.G., Prevette D., Caress J., Oppenheim R.W., Milligan C. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part I, background and methods. Brain Behav. 2013;3:335&#x2013;350. doi: 10.1002/brb3.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.143</ArticleId><ArticleId IdType="pmc">PMC3869677</ArticleId><ArticleId IdType="pubmed">24381807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo J.J., Schonewille M., Siddique T., Schults A.N.A., Fu R., B&#xe4;r P.R., Anelli R., Heckman C.J., Kroese A.B.A. Hyperexcitability of Cultured Spinal Motoneurons from Presymptomatic ALS Mice. J. Neurophysiol. 2004;91:571&#x2013;575. doi: 10.1152/jn.00665.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00665.2003</ArticleId><ArticleId IdType="pubmed">14523070</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999;2:50&#x2013;56. doi: 10.1038/4553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4553</ArticleId><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Amendola J., Verrier B., Roubertoux P., Durand J. Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2004;20:2822&#x2013;2826. doi: 10.1111/j.1460-9568.2004.03745.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2004.03745.x</ArticleId><ArticleId IdType="pubmed">15548226</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zundert B., Peuscher M.H., Hynynen M., Chen A., Neve R.L., Brown R.H., Constantine-Paton M., Bellingham M.C. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Neurosci. 2008;28:10864&#x2013;10874. doi: 10.1523/JNEUROSCI.1340-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1340-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844745</ArticleId><ArticleId IdType="pubmed">18945894</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S., Mansfield C., Jimenez-Moreno R., Moore V.D.G., Yoshikawa M., Hampton T.G., Prevette D., Caress J., Oppenheim R.W., Milligan C. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part II, results and discussion. Brain Behav. 2013;3:431&#x2013;457. doi: 10.1002/brb3.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.142</ArticleId><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto R.G., Mustafi S.M., Amin M.Y., Mareci T.H., Wu Y.-C., Magin R.L. Neurite Orientation Dispersion and Density Imaging Can Detect Presymptomatic Axonal Degeneration in The Spinal Cord of ALS Mice. Funct. Neurol. 2018;33:155&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212765</ArticleId><ArticleId IdType="pubmed">30457969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechler M.E., Byrne L., Ffrench-Constant C. CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes. Curr. Biol. 2015;25:2411&#x2013;2416. doi: 10.1016/j.cub.2015.07.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.07.056</ArticleId><ArticleId IdType="pmc">PMC4580335</ArticleId><ArticleId IdType="pubmed">26320951</ArticleId></ArticleIdList></Reference><Reference><Citation>Benned-Jensen T., Rosenkilde M. Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants. Br. J. Pharmacol. 2010;159:1092&#x2013;1105. doi: 10.1111/j.1476-5381.2009.00633.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2009.00633.x</ArticleId><ArticleId IdType="pmc">PMC2839267</ArticleId><ArticleId IdType="pubmed">20148890</ArticleId></ArticleIdList></Reference><Reference><Citation>Buccioni M., Marucci G., Ben D.D., Giacobbe D., Lambertucci C., Soverchia L., Thomas A., Volpini R., Cristalli G. Innovative functional cAMP assay for studying G protein-coupled receptors: Application to the pharmacological characterization of GPR17. Purinergic Signal. 2011;7:463&#x2013;468. doi: 10.1007/s11302-011-9245-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-011-9245-8</ArticleId><ArticleId IdType="pmc">PMC3224640</ArticleId><ArticleId IdType="pubmed">21773766</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppi E., Maraula G., Fumagalli M., Failli P., Cellai L., Bonfanti E., Mazzoni L., Coppini R., Abbracchio M.P., Pedata F., et al. UDP-glucose enhances outward K + currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors. Glia. 2013;61:1155&#x2013;1171. doi: 10.1002/glia.22506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22506</ArticleId><ArticleId IdType="pubmed">23640798</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniele S., Trincavelli M.L., Gabelloni P., Lecca D., Rosa P., Abbracchio M.P., Martini C. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: A functional cross-talk between purinergic and cysteinyl-leukotriene ligands. J. Pharmacol. Exp. Ther. 2011;338:559&#x2013;567. doi: 10.1124/jpet.110.178715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.110.178715</ArticleId><ArticleId IdType="pubmed">21531793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennen S., Wang H., Peters L., Merten N., Simon K., Spinrath A., Bl&#xe4;ttermann S., Akkari R., Schrage R., Schr&#xf6;der R., et al. Decoding signaling and function of the orphan g protein-coupled receptor GPR17 with a small-molecule agonist. Sci. Signal. 2013;6:ra93. doi: 10.1126/scisignal.2004350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2004350</ArticleId><ArticleId IdType="pmc">PMC4114018</ArticleId><ArticleId IdType="pubmed">24150254</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa A., Balestrieri B., Austen K.F., Kanaoka Y. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc. Natl. Acad. Sci. USA. 2009;106:11685&#x2013;11690. doi: 10.1073/pnas.0905364106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905364106</ArticleId><ArticleId IdType="pmc">PMC2710631</ArticleId><ArticleId IdType="pubmed">19561298</ArticleId></ArticleIdList></Reference><Reference><Citation>Merten N., Fischer J., Simon K., Zhang L., Schr&#xf6;der R., Peters L., Letombe A.G., Hennen S., Schrage R., B&#xf6;defeld T., et al. Repurposing HAMI3379 to Block GPR17 and Promote Rodent and Human Oligodendrocyte Differentiation. Cell Chem. Biol. 2018;25:775&#x2013;786. doi: 10.1016/j.chembiol.2018.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2018.03.012</ArticleId><ArticleId IdType="pmc">PMC6685917</ArticleId><ArticleId IdType="pubmed">29706593</ArticleId></ArticleIdList></Reference><Reference><Citation>Parravicini C., Abbracchio M.P., Fantucci P., Ranghino G. Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach. BMC Struct. Biol. 2010;10:8. doi: 10.1186/1472-6807-10-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6807-10-8</ArticleId><ArticleId IdType="pmc">PMC2850907</ArticleId><ArticleId IdType="pubmed">20233425</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi A.D., Kendall Harden T., Nicholas R.A. Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17. J. Pharmacol. Exp. Ther. 2013;347:38&#x2013;46. doi: 10.1124/jpet.113.207647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.113.207647</ArticleId><ArticleId IdType="pmc">PMC3781415</ArticleId><ArticleId IdType="pubmed">23908386</ArticleId></ArticleIdList></Reference><Reference><Citation>Marschallinger J., Sch&#xe4;ffner I., Klein B., Gelfert R., Rivera F.J., Illes S., Grassner L., Janssen M., Rotheneichner P., Schmuckermair C., et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat. Commun. 2015;6:1&#x2013;16. doi: 10.1038/ncomms9466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9466</ArticleId><ArticleId IdType="pmc">PMC4639806</ArticleId><ArticleId IdType="pubmed">26506265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>